# A Bioequivalence Study of Advil Dual Action Liquid Filled Capsules (125 mg/250 mg) Versus Advil Dual Action Caplets (125 mg/250 mg) and Bioavailability Assessment of Advil Dual Action Liquid Filled Capsules (125 mg/250 mg) and Advil Liqui-Gels (200 mg) in Healthy Adult Subjects

> **NCT06802185** · PHASE1 · COMPLETED · sponsor: **HALEON** · enrollment: 54 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** ADA Liquid Filled Capsules (Test Product)
- **DRUG:** ADA Caplets (Reference Product)
- **DRUG:** Advil Liqui-gels (Reference Product)

## Key facts

- **NCT ID:** NCT06802185
- **Lead sponsor:** HALEON
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-31
- **Primary completion:** 2025-04-12
- **Final completion:** 2025-04-12
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2025-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06802185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06802185, "A Bioequivalence Study of Advil Dual Action Liquid Filled Capsules (125 mg/250 mg) Versus Advil Dual Action Caplets (125 mg/250 mg) and Bioavailability Assessment of Advil Dual Action Liquid Filled Capsules (125 mg/250 mg) and Advil Liqui-Gels (200 mg) in Healthy Adult Subjects". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06802185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*